Either lipodeficient serum supplementation or HMG-CoA reductase inhibition significantly reduced the CE level (Figure 3g), indicating that both de novo synthesis and LDL uptake pathways contribute to CE accumulation in pancreatic cancer cells. The gene discussed is HMGCR; the disease is pancreatic neoplasm.